Adaptation of SARS Coronavirus to Humans
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
(Uploaded by Plazi for the Bat Literature Project) No abstract provided.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923
Guan, Y., Zheng, B. J., He, Y. Q., Liu, X. L., Zhuang, Z. X., Cheung, C. L., Luo, S. W., Li, P. H., Zhang, L. J., Guan, Y. J., et al. (2003) · Science · doi:10.1126/science.1087139 · Cited by 2,406
Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor
Li, F., Li, W., Farzan, M., & Harrison, S. C. (2005) · Science · doi:10.1126/science.1116480 · Cited by 2,031
Identification of a new human coronavirus
van der Hoek, L., Pyrc, K., Jebbink, M. F., Vermeulen-Oost, W., Berkhout, R. J. M., Wolthers, K. C., Wertheim-van Dillen, P. M. E., Kaandorp, J., Spaargaren, J., & Berkhout, B. (2004) · Nature Medicine · doi:10.1038/nm1024 · Cited by 1,886
Receptor and viral determinants of SARS‐coronavirus adaptation to human ACE2
Li, W., Zhang, C., Sui, J., Kuhn, J. H., Moore, M. J., Luo, S., Wong, S., Huang, I., Xu, K., Vasilieva, N., et al. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600640 · Cited by 988
Hofmann, H., Pyrc, K., van der Hoek, L., Geier, M., Berkhout, B., & Pöhlmann, S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409465102 · Cited by 824
Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human
Song, H.-D., Tu, C.-C., Zhang, G.-W., Wang, S.-Y., Zheng, K., Lei, L.-C., Chen, Q.-X., Gao, Y.-W., Zhou, H.-Q., Xiang, H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409608102 · Cited by 701
Glaser, L., Stevens, J., Zamarin, D., Wilson, I. A., García-Sastre, A., Tumpey, T. M., Basler, C. F., Taubenberger, J. K., & Palese, P. (2005) · Journal of Virology · doi:10.1128/jvi.79.17.11533-11536.2005 · Cited by 400
Babcock, G. J., Esshaki, D. J., Thomas, W. D., & Ambrosino, D. M. (2004) · Journal of Virology · doi:10.1128/jvi.78.9.4552-4560.2004 · Cited by 243
He, Y., Lu, H., Siddiqui, P., Zhou, Y., & Jiang, S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.4908 · Cited by 241
Research works printed but not linked: 1
- Lai M. M. C., Holmes K. V., Fields' Virology,, Knipe D. M., Howley P. M., Eds. (Lippincott Williams and Wilkins, Philadelphia, 2001) 3..
Cited by
Graham, R. L., & Baric, R. S. (2010) · Journal of Virology · doi:10.1128/jvi.01394-09 · Cited by 751
Bat-to-human: spike features determining ‘host jump’ of coronaviruses SARS-CoV, MERS-CoV, and beyond
Lu, G., Wang, Q., & Gao, G. F. (2015) · Trends in Microbiology · doi:10.1016/j.tim.2015.06.003 · Cited by 607
“In light of the inefficiency of SARS-CoV RBD in recognizing the mouse and rat receptors, it is unlikely that these two species are involved in the SARS-CoV zoonosis.”
BackgroundBreban, R., Riou, J., & Fontanet, A. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61492-0 · Cited by 385
"Super-Spreaders" and Person-to-Person Transmission of Andes Virus in Argentina
Martínez, V. P., Di Paola, N., Alonso, D. O., Pérez-Sautu, U., Bellomo, C. M., Iglesias, A. A., Coelho, R. M., López, B., Periolo, N., Larson, P. A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2009040 · Cited by 247
Kim, J.-K., Fahad, A.-M., Shanmukhappa, K. S., & Kapil, S. (2005) · Journal of Virology · doi:10.1128/jvi.80.2.689-696.2006 · Cited by 164
Frieman, M., Yount, B., Agnihothram, S., Page, C., Donaldson, E., Roberts, A., Vogel, L., Woodruff, B., Scorpio, D., Subbarao, K., et al. (2012) · Journal of Virology · doi:10.1128/jvi.05957-11 · Cited by 138
Hofmann, H., Simmons, G., Rennekamp, A. J., Chaipan, C., Gramberg, T., Heck, E., Geier, M., Wegele, A., Marzi, A., Bates, P., et al. (2006) · Journal of Virology · doi:10.1128/jvi.00560-06 · Cited by 125
Advances in research on ACE2 as a receptor for 2019-nCoV
Wu, J., Deng, W., Li, S., & Yang, X. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03611-x · Cited by 122
Hemida, M. G., Perera, R. A. P. M., Jassim, R. A. M. A., Kayali, G., Siu, L. Y.-L., Wang, P., Chu, K. W., Perlman, S. M., Ali, M. A., Alnaeem, A. A., et al. (2014) · Eurosurveillance · doi:10.2807/1560-7917.es2014.19.23.20828 · Cited by 120
Molecular Biology of the SARS-Coronavirus
Lal, S. K. (2010) · Springer eBooks · doi:10.1007/978-3-642-03683-5 · Cited by 103
Chan, R. W. Y., Hemida, M. G., Kayali, G., Chu, D. K. W., Poon, L. L. M., Alnaeem, A. A., Ali, M. A., Tao, K. P., Ng, H. Y., Chan, M. C. W., et al. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70158-4 · Cited by 102
Struck, A., Axmann, M., Pfefferle, S., Drosten, C., & Meyer, B. (2012) · Antiviral Research · doi:10.1016/j.antiviral.2011.12.012 · Cited by 97
“Especially, the introduction of a threonine residue at position 487 and an asparagine instead of a charged lysine residue at position 479 of the spike protein seem to be responsible for its high affinity to human ACE2 (Holmes, 2005; Li et al., 2005b; Qu et al., 2005).”
BackgroundAssessing the pandemic potential of MERS-CoV
Bauch, C. T., & Oraby, T. F. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61504-4 · Cited by 96
Nanomedicine for the SARS-CoV-2: State-of-the-Art and Future Prospects
Varahachalam, S. P., Lahooti, B., Chamaneh, M., Bagchi, S., Chhibber, T., Morris, K., Bolanos, J. F., Kim, N., & Kaushik, A. K. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s283686 · Cited by 102
Coughlin, M. M., & Prabhakar, B. S. (2012) · Reviews in Medical Virology · doi:10.1002/rmv.706 · Cited by 87
Poletto, C., Pelat, C., Lévy-Bruhl, D., Yazdanpanah, Y., Boëlle, P., & Colizza, V. (2014) · Eurosurveillance · doi:10.2807/1560-7917.es2014.19.23.20824 · Cited by 83
Viral Host Jumps: Moving toward a Predictive Framework
Pulliam, J. R. C. (2008) · EcoHealth · doi:10.1007/s10393-007-0149-6 · Cited by 79
“…to generate genetic diversity may be necessary for significant transmission within a novel host species (Antia et al., 2003), as was seen with SARS (Holmes, 2005); however, a more accurate assessment of propagation potential requires a detailed understanding of the determinants of cellular…”
BackgroundMethodInfluentialSáinz, B., Mossel, E. C., Gallaher, W. R., Wimley, W. C., Peters, C. J., Wilson, R. B., & Garry, R. F. (2006) · Virus Research · doi:10.1016/j.virusres.2006.03.001 · Cited by 73
“(Goldsmith et al., 2004; Holmes, 2005; Peiris et al., 2003b).”
A structural view of coronavirus–receptor interactions
Reguera, J., Mudgal, G., Santiago, C. A., & Casasnovas, J. M. (2014) · Virus Research · doi:10.1016/j.virusres.2014.10.005 · Cited by 61
“All rights reserved. adaptation to the use of orthologous receptor molecules (Graham and Baric, 2010; Holmes, 2005).”
BackgroundInfluentialAwadasseid, A., Wu, Y., Tanaka, Y., & Zhang, W. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.47827 · Cited by 59
“Previous studies on the relationship between the SARS-related CoV (SARSr-CoV) S protein and ACE2 demonstrate that several amino acid substitutions are required for the foreign S-protein to bind to the homologous receptor of the current host species [23-25].”
BackgroundKeng, C. T., Choi, Y., Welkers, M. R. A., Chan, D. Z. L., Shen, S., Lim, S. G., Hong, W., & Tan, Y. (2006) · Virology · doi:10.1016/j.virol.2006.06.026 · Cited by 56
“Although it is clear that the S gene was undergoing positive selection (Holmes, 2005) , whether the genetic variation in the ORF8 region is a result of viral adaptation or genomic instability remains to be deter-mined.”
BackgroundMahajan, M. K., & Bhattacharjya, S. (2014) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2014.11.025 · Cited by 43
“During 2002-2003, SARS-CoV emerged as a global health risk which was speared over 29 countries infecting approximately 9000 people with 774 deaths worldwide [30] [31] [32] .”
BackgroundSevere Acute Respiratory Syndrome Coronavirus (SARS-CoV)
Tong, T. R. S.-W. (2006) · Perspectives in medical virology · doi:10.1016/s0168-7069(06)16004-8 · Cited by 43
“The avidity of binding (Li et al., 2005e) , viral entry (Yi et al., 2005) , and immunogenicity (Yi et al., 2005) are affected by single amino acid substitutions within this region, as demonstrated at 2.9 Å resolution (Holmes, 2005; Li et al., 2005b) .”
InfluentialYu, M., Stevens, V., Berry, J. D., Crameri, G. S., McEachern, J. A., Tu, C., Shi, Z., Liang, G., Weingartl, H. M., Cardosa, J., et al. (2007) · Journal of Immunological Methods · doi:10.1016/j.jim.2007.11.009 · Cited by 35
“Knowing that SARS–CoV originated from an animal reservoir and animals played a key role in the adaptation and transmission to the human population (Holmes 2005; Li et al., 2006), accurate diagnosis of SARS–CoV infection among different animals species should be an important and integral part of an effective prevention…”
Evolution, Ecology, and Zoonotic Transmission of Betacoronaviruses: A Review
Jelinek, H. F., Mousa, M., Alefishat, E. A., Osman, W. M., Spence, I., Bu, D., Feng, S. F., Byrd, J. H., Magni, P. A., Sahibzada, S., et al. (2021) · Frontiers in Veterinary Science · doi:10.3389/fvets.2021.644414 · Cited by 31
Reguera, J., Ordoño, D., Santiago, C. A., Enjuanes, L., & Casasnovas, J. M. (2011) · Journal of General Virology · doi:10.1099/vir.0.027607-0 · Cited by 26
“…in 2002, the interest in CoVs has increased dramatically as potential generators of new, serious zoonotic infectious diseases (Drosten et al., 2003; Holmes, 2005; Lau, 2004; Rota et al., 2003), making evident the necessity for a deeper understanding of the determinants responsible for CoV receptor…”
Lectin-like Intestinal Defensin Inhibits 2019-nCoV Spike binding to ACE2Preprint
Wang, C., Wang, S., Li, D., Zhao, X., Han, S., Wang, T., Zhao, G., Chen, Y., Chen, F., Zhao, J., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.29.013490 · Cited by 27
Immune Evasive Effects of SARS-CoV-2 Variants to COVID-19 Emergency Used Vaccines
Zhang, Y., Ndzouboukou, J. B., Gan, M., Lin, X., & Fan, X. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.771242 · Cited by 26
“org 2 of the virus in infected people (8).”
BackgroundMahajan, M. K., Chatterjee, D., Kannaian, B., Pillay, S., & Bhattacharjya, S. (2017) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2017.10.002 · Cited by 22
Tsunetsugu‐Yokota, Y., Ato, M., Takahashi, Y., Hashimoto, S., Kaji, T., Kuraoka, M., Yamamoto, K., Mitsuki, Y.-Y., Yamamoto, T., Oshima, M., et al. (2007) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2007.106 · Cited by 22
Kang, X., Yang, B.-A., Hu, Y., Zhao, H. J., Xiong, W., Yang, Y., Si, B., & Zhu, Q. (2006) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00037-06 · Cited by 21
Yan, Z., Tripet, B., & Hodges, R. S. (2006) · Journal of Structural Biology · doi:10.1016/j.jsb.2006.03.024 · Cited by 21
“Infection by SARS coronavirus requires fusion of the viral and cellular membranes, which is mediated by the viral envelope Spike (S) glycoprotein and receptors on the target cell (Holmes, 2005).”
BackgroundPrediction of cross-species infection propensities of viruses with receptor similarity
Cho, M., & Son, H. S. (2019) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2019.04.016 · Cited by 20
“Considering the actual host range of SARS-CoV (Martina et al., 2003; Holmes, 2005), these findings confirm that the difference in Infectindex value reflects the infection properties of the virus.”
BackgroundThe inhibitory effect of a coronavirus spike protein fragment with ACE2
Peter, E. K., & Schug, A. H. (2020) · Biophysical Journal · doi:10.1016/j.bpj.2020.08.022 · Cited by 20
“One of the key factors for its infectious potential for humans is the high conservation of ACE2 in different mammalian organisms (18), which allows its transmission from animals to humans.”
Roberts, A., Wood, J., Subbarao, K., Ferguson, M., Wood, D., & Cherian, T. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.07.009 · Cited by 16
“Only four amino acid residues in the receptor glycoprotein ACE2binding domain of the viral spike protein differ between the human epidemic SARS-CoV strains and civet strains, but they cause more than a 1000-fold difference in binding affinity to the ACE2 molecule [13, 14] .”
BackgroundWhen Successive Viral Mutations Prevent Definitive Treatment of COVID-19
Mohammadi, M. R., & Sabati, H. (2022) · Cellular Molecular and Biomedical Reports · doi:10.55705/cmbr.2022.339012.1040 · Cited by 13
“According to earlier studies on the interaction between the SARS-related CoV (SARSr-CoV) S protein and ACE2, certain amino acid modifications are required for the foreign S-protein to connect to the homologous receptor of the current host species [22-24].”
Keng, C. T., & Tan, Y. (2009) · Springer eBooks · doi:10.1007/978-3-642-03683-5_12 · Cited by 11
“While it is clear that the S gene was undergoing positive selection (Holmes 2005; Zhao 2007 ), whether the genetic variation in the ORF8 region is a result of viral adaptation or genomic instability remains to be determined.”
BackgroundThe basis of mink susceptibility to SARS-CoV-2 infection
Barua, A., Grot, N., & Pławski, A. (2022) · Journal of Applied Genetics · doi:10.1007/s13353-022-00689-w · Cited by 10
“The change of only 2–4 amino acids in the RBD can cause even 1000-fold differences in binding affinity to ACE2 (Holmes 2005).”
BackgroundEvolution of the uniquely adaptable lentiviral envelope in a natural reservoir host
Demma, L., Vanderford, T. H., Logsdon, J., Feinberg, M. B., & Staprans, S. I. (2006) · Retrovirology · doi:10.1186/1742-4690-3-19 · Cited by 10
“Studies of zoonotic RNA virus diversity have not focused on the variation that already exists in the source reservoir hosts; rather, the focus has largely been on the genetic variation and specific adaptive mutations that are observed in the newly emerged human pathogen [36, 37] .”
BackgroundCorrelation of the virulence of CSFV with evolutionary patterns of E2 glycoprotein
Chen, J. (2010) · Frontiers in Bioscience-Elite · doi:10.2741/e83 · Cited by 10
Vanderford, T. H., Demma, L. J., Feinberg, M. B., Staprans, S. I., & Logsdon, J. M., Jr. (2006) · Molecular Biology and Evolution · doi:10.1093/molbev/msl194 · Cited by 8
“1999; Holmes 2005; Leroy et al.”
BackgroundXu, D., Huimin, S., Su, H., Zhang, L., Jingxia, Z., Wang, B., & Xu, R. (2014) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20131328 · Cited by 8
The inhibitory effect of a Corona virus spike protein fragment with ACE2Preprint
Peter, E. K., & Schug, A. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.03.132506 · Cited by 7
Watabe, T., Kishino, H., Martins, L. D. O., & Kitazoe, Y. (2007) · Molecular Biology and Evolution · doi:10.1093/molbev/msm079 · Cited by 6
“Adaptation of a virus to a homologous receptor of a new host species appears to require very few amino acid substitutions at the large receptor-binding interface (Holmes 2005) .”
BackgroundVirus–Receptor Interactions and Receptor-Mediated Virus Entry into Host Cells
Casasnovas, J. M. (2024) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-65187-8_15 · Cited by 6
Iglesias‐Caballero, M., Más, V., Vázquez‐Morón, S., Vázquez, M., Camarero-Serrano, S., Cano, O., Palomo, C., Ruano, M. J., Cano‐Gómez, C., Infantes‐Lorenzo, J. A., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105499 · Cited by 4
In silico screening and molecular docking of bioactive agents towards human coronavirus receptor
Kumar, P., Asnani, A. J., Chaple, D., & Abhinav, B. G. (2020) · GSC Biological and Pharmaceutical Sciences · doi:10.30574/gscbps.2020.11.1.0099 · Cited by 4
Applications of Protein Secondary Structure Algorithms in SARS-CoV-2 Research
Kruglikov, A., Rakesh, M., Wei, Y., & Xia, X. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00734 · Cited by 4
Why do some coronaviruses become pandemic threats when others do not?
Rice, B. L., Lessler, J., McKee, C., & Metcalf, C. J. E. (2022) · PLoS Biology · doi:10.1371/journal.pbio.3001652 · Cited by 5
“This would then increase opportunities for further response to selection, as we have seen with the emergence of improved receptor binding for SARS-CoV-1 [18] and increasingly transmissible variants of SARS-CoV-2 [19].”
BackgroundCOVID-19 pandemic and “survival of the fittest”
Mukhra, R., Krishan, K., & Kanchan, T. (2021) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.13490 · Cited by 3
Vaccines and global stability: achievements and challenges
van der Zeijst, B. A. M. (2008) · Expert Review of Vaccines · doi:10.1586/14760584.7.10.1457 · Cited by 3
The potential of targeted antibody prophylaxis in SARS outbreak control: A mathematic analysis
Bogaards, J. A., Putter, H., Weverling, G. J., ter Meulen, J., & Goudsmit, J. (2006) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2006.01.007 · Cited by 2
“SARS coronavirus, the causative agent of the new disease,(5,6) most likely was transmitted to humans by the masked palm civet (Paguma larvata).(7) Adaptation to human transmission is possible through a single mutation in the spike glycoprotein of a civet SARS-like virus.”
BackgroundGarcía‐Marín, J., Francés‐Gómez, C., Forcada‐Nadal, A., Adhav, A. S., Marco‐Marín, C., Rubio, V., Marina, A., Llacer, J. L., Geller, R., & Martín‐Santamaría, S. (2025) · ACS Omega · doi:10.1021/acsomega.5c05175 · Cited by 1
Wang, L. (2009) · Microbiology Australia · doi:10.1071/ma09122 · Cited by 1
COVID-19-Infektion – Update: Was muss der Gefäßmediziner wissen?
Gassanov, N., Lambur, H. B., & Er, F. (2020) · Gefässchirurgie · doi:10.1007/s00772-020-00691-8 · Cited by 1
How do viruses assemble and infect their host cells?
(2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99893-2.00003-8 · Cited by 1
Development of Instantaneous Protection against SARS-CoV with Implications for Multiple RNA Viruses
Elshabrawy, H. A. (2012) · Figshare
Assessing the pandemic potential of MERS-CoV
Opie, L. H. (2013)
Lum, G. (2012) · Louisiana State University · doi:10.31390/gradschool_dissertations.3564 · Cited by 1
“It has been proposed that, at least for the SARS-CoV, Nsp8 may in fact act as a primase in concert with nsp7 and be responsible for synthesizing the short oligo primers that are then utilized by Nsp12 for RNA synthesis (Imbert et al., 2006; te Velthuis et al., 2009; te Velthuis et al., 2012).”
BackgroundInfluentialThe effect of salt on the dynamics of CoV-2 RBD at ACE2Preprint
Peter, E. K., & Schug, A. H. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.09.333948
“Notably, one of the key factors for its infectious potential for humans is the high conservation of ACE2 in different mammalian organisms (16), which allows its transmission from animals to humans.”
BackgroundWang, S., Xiao, F., He, L., Yang, J., & Wei, H. (2021) · Research Square · doi:10.21203/rs.3.rs-407527/v1
A szimuláció vége: a vírusválság allegóriája
Gyuris, N. (2022) · Performa · doi:10.24361/performa.2022.13.6
A Review: Bovine Coronavirus Evolution, Molecular Epidemiology, and Genetic Variation
Wang, D., Zhang, W., Nie, Z., Wang, X., Liu, J., Zhang, Y., Lu, Y., Mai, Z., He, X., Li, J., et al. (2026) · Viruses · doi:10.3390/v18080909 · Cited by 1
Metadata
- Authors
- Holmes, K. V.
- Affiliations
- University of Colorado Health (US)
- Corresponding author
- Holmes, Kathryn V.
- Venue
- Science
- Published
- 2005-09-16
- Volume
- 309
- Issue
- 5742
- Pages
- 1822-1823
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1666751903
- Cited by
- 63
- References
- 14
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 3 · 2022: 4 · 2021: 6 · 2020: 9 · 2019: 1 · 2017: 1 · 2015: 1 · 2014: 6 · 2013: 3 · 2012: 3
- FWCI
- 3.41
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Zenodo (CERN European Organization for Nuclear Research)
- Funders
- National Institute of Allergy and Infectious Diseases (AI59578)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Zoonotic diseases and public health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
- Keywords
- SARS coronavirus, zoonotic transmission, host adaptation, bats, coronavirus evolution, human infection
- MeSH terms
- Angiotensin-Converting Enzyme 2, Adaptation, Physiological, Animals, Binding Sites, Carboxypeptidases, Disease Outbreaks, Genes, Viral, Humans, Peptidyl-Dipeptidase A, Membrane Glycoproteins, Mutation, Receptors, Virus, Recombination, Genetic, RNA, Viral, Species Specificity, Viral Envelope Proteins, Viral Vaccines, Virus Replication, Protein Structure, Tertiary, Amino Acid Substitution, Severe Acute Respiratory Syndrome, Severe acute respiratory syndrome-related coronavirus, Viverridae, Hydrophobic and Hydrophilic Interactions, Spike Glycoprotein, Coronavirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.